对动脉样硬化治疗的基因疗法方法侧重于向脂质代谢和炎症
Evgeny Bezsonov1,2, Nikita Chernyi1, Mane Saruhanyan1,2
1Laboratory of Molecular Virology, First Moscow State Medical University (Sechenov University), Moscow 119435, Russia.
International journal of molecular sciences
|July 29, 2025
概括
基因疗法提供了一种有前途的新方法,通过向关键分子通路来预防和治疗动脉样硬化. 研究探索病毒载体和新型基因标,以对抗这种复杂的动脉疾病.
科学领域:
- 心血管研究研究心血管研究
- 分子医学是分子医学.
- 基因治疗 基因治疗
背景情况:
- 动脉样硬化涉及动脉内脏的加厚,由脂质积累和炎症驱动.
- 目前的治疗方法缺乏有效的预防,尽管了解分子病原性.
- 饮食和遗传学等危险因素加剧动脉样硬化,但缺乏明确的作用.
研究的目的:
- 审查基因治疗的基因标,作为潜在的治疗和预防性治疗动脉样硬化.
- 为了评估基于病毒载体的基因疗法 (AAV,lentivirus) 用于动脉样硬化治疗.
- 探索替代基因向方法,以限制疾病进展.
主要方法:
- 对动脉样硬化基因治疗的最新研究进行审查.
- 基于病毒载体的方法 (AAV,lentivirus) 的分析.
- 替代基因标的总结:ncRNA,miRNA,siRNA,ASO,CRISPR/Cas9. 这些基因标的基因是不同的.
主要成果:
- 基于病毒载体的基因疗法显示出对动脉样硬化的治疗潜力.
- 替代基因标和方法可以限制疾病的进展.
- 具有抗炎活性的基因标对于抑制病理反应至关重要.
结论:
- 基因疗法为动脉样硬化的预防和治疗提供了一种新的策略.
- 基因疗法的进步为对抗动脉样硬化提供了新的途径.
- 通过基因疗法向局部炎症是抑制动脉样硬化进展的关键.
相关概念视频
Atherosclerosis III: Management
35
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
35
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
875
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
875
Atherosclerosis I: Introduction
87
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
87
Coronary Artery Disease I: Introduction
58
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
58
Inflammation
55.2K
Overview
55.2K
Atherosclerosis IV: Nursing Management
51
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
51


